Skip to Main Content

Paper Details

COVID-19 and androgen-targeted therapy for prostate cancer patients.
Endocr Relat Cancer
47
2020
ACE2, Androgen, COVID, COVID-19, SARS, SARS-, SARS-CoV, SARS-CoV-2, TMPRSS2, androgen, androgen receptor, androgen-responsive gene, angiotensin converting enzyme 2, coronavirus 2, host cells, human, patients, prostate cancer, serine, severe acute respiratory syndrome coronavirus, transmembrane serine protease 2
Author NameAffiliation
Neeraj AgarwalUniversity of Utah Huntsman Cancer Institute
Edwin M Posadas
Stephen J Freedland
  • 1 - 3

Datasets

Release 1.2